157 related articles for article (PubMed ID: 6759334)
21. [Clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
Uchida S; Hayashi H; Tominaga M; Kohno K; Matsunaga M; Kudo S; Kawamura R
Jpn J Antibiot; 1983 Sep; 36(9):2549-55. PubMed ID: 6655869
[TBL] [Abstract][Full Text] [Related]
22. [Clinical effect of cefroxadine on surgical infections].
Aikawa T; Noguchi S; Fujimoto N; Mizushima H; Shibata N; Tomita N; Horii A
Jpn J Antibiot; 1983 Sep; 36(9):2521-8. PubMed ID: 6686263
[TBL] [Abstract][Full Text] [Related]
23. Comparative double-blind trial of cephalexin and ampicillin in treatment of urinary infections.
Davies JA; Strangeways JE; Mitchell RG; Beilin LJ; Ledingham JG; Holt JM
Br Med J; 1971 Jul; 3(5768):215-7. PubMed ID: 4934374
[TBL] [Abstract][Full Text] [Related]
24. A newer cephalosporin (cephradine) in the treatment of urinary tract infections.
Gulati PD; Agarwal DS; Baweja U; Sethi K; Geeta V
J Assoc Physicians India; 1977 Apr; 25(4):249-54. PubMed ID: 334716
[No Abstract] [Full Text] [Related]
25. [Clinical trials with cefroxadine dry syrup in the treatment of infectious disease of children (author's transl)].
Furukawa S; Okada T; Hirao F
Jpn J Antibiot; 1981 Dec; 34(12):1697-702. PubMed ID: 7038188
[TBL] [Abstract][Full Text] [Related]
26. [Study of cefroxadine in pediatrics regarding clinical efficacy and serum levels (author's transl)].
Iwasaki Y; Iwata S; Kanemitsu T; Jozaki K; Hattori H; Akita H; Hotta M; Yamashita N; Nanri S; Sunakawa K; Oikawa T; Osano M; Ichihashi Y; Kuratsuji T; Haginiwa Y
Jpn J Antibiot; 1981 Dec; 34(12):1595-603. PubMed ID: 7334584
[TBL] [Abstract][Full Text] [Related]
27. [Absorption, excretion and clinical trials of cefroxadine in the field of pediatrics (author's transl)].
Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Takajo N; Araki H; Shiozuki Y; Takenaka S; Kamezaki K; Yoshinaga Y; Kawano N; Yamamoto M; Komatsu R; Ohta M; Etoh Y; Moroi T; Iriki T; Chou H; Okada S; Kinoshita M; Imuta F; Koga T
Jpn J Antibiot; 1981 Dec; 34(12):1703-31. PubMed ID: 7038189
[TBL] [Abstract][Full Text] [Related]
28. [Experimental and clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
Cho N; Araki H; Ishikawa T; Kunii K; Fukunaga K; Deguchi K
Jpn J Antibiot; 1983 Sep; 36(9):2535-48. PubMed ID: 6655868
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study of cefroxadine in the field of obstetrics and gynecology].
Okada N; Sugimoto Y; Suno N; Shikato Y
Jpn J Antibiot; 1983 Sep; 36(9):2556-61. PubMed ID: 6655870
[TBL] [Abstract][Full Text] [Related]
30. [Laboratory and clinical studies on cefroxadine (author's transl)].
Nishikawa K; Aso K; Miyachi Y; Ogawa A; Yafuso M; Kuno K
Jpn J Antibiot; 1981 Dec; 34(12):1647-54. PubMed ID: 7334589
[TBL] [Abstract][Full Text] [Related]
31. [Laboratory and clinical studies cefroxadine in pediatric field (author's transl)].
Kawamura Y; Nomura T; Ihara T; Shimizu S; Kamiya H; Sakurai M; Nishi H
Jpn J Antibiot; 1981 Dec; 34(12):1655-62. PubMed ID: 7334590
[TBL] [Abstract][Full Text] [Related]
32. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic.
Levison ME; Johnson WD; Thornhill TS; Kaye D
JAMA; 1969 Sep; 209(9):1331-6. PubMed ID: 4895869
[No Abstract] [Full Text] [Related]
33. [Treatment of urinary tract infections with cephalexin an oral antibiotic of cephalosporin-group].
Hofmeister H; Scharrer G; Sawallisch R
Arzneimittelforschung; 1970 Jan; 20(1):139-42. PubMed ID: 4986282
[No Abstract] [Full Text] [Related]
34. Cephalexin in the therapy of infections of the urinary tract.
Weinstein AJ
Postgrad Med J; 1983; 59 Suppl 5():40-2. PubMed ID: 6664942
[TBL] [Abstract][Full Text] [Related]
35. [Clinical experience with cefroxadine in bacterial infection of children (author's transl)].
Sekiguchi T; Hosoda T; Ichioka T; Miyao M; Kokawa T; Uyama Y; Tanaka H
Jpn J Antibiot; 1981 Dec; 34(12):1691-6. PubMed ID: 7334593
[TBL] [Abstract][Full Text] [Related]
36. Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
Hubsher JA; Gadebusch HH; Itkin AG
Curr Ther Res Clin Exp; 1976 Jun; 19(6):579-88. PubMed ID: 819217
[No Abstract] [Full Text] [Related]
37. [New oral cephem antibiotic, cefroxadine capsules, against superficial suppurative disease in the field of surgery].
Abe N; Sakurai K
Jpn J Antibiot; 1983 Sep; 36(9):2515-20. PubMed ID: 6655866
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)].
Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Eandi M
Minerva Med; 1981 Apr; 72(13):813-8. PubMed ID: 7219791
[TBL] [Abstract][Full Text] [Related]
39. The role of cefadroxil in the therapy of urinary tract infections.
Wilber RB; DeRegis RG; Fox EJ
J Antimicrob Chemother; 1982 Sep; 10 Suppl B():77-84. PubMed ID: 7142098
[No Abstract] [Full Text] [Related]
40. CGP 9000: a new orally active, broad-spectrum cephalosporin.
Zak O; Vischer WA; Schenk C; Tosch W; Zimmermann W; Regös J; Suter ER; Kradolfer F; Gelzer J
J Antibiot (Tokyo); 1976 Jun; 29(6):653-5. PubMed ID: 950320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
